Literature DB >> 23740787

Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo.

Tae Hyung Kim1, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh-Nasseri, Martin G Pomper, Kang Choon Lee, Seulki Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740787      PMCID: PMC3902477          DOI: 10.1002/anie.201302181

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  26 in total

Review 1.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Authors:  Avi Ashkenazi
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  PEGylated TNF-related apoptosis-inducing ligand (TRAIL) analogues: pharmacokinetics and antitumor effects.

Authors:  Tae Hyung Kim; Yu Seok Youn; Hai Hua Jiang; Seulki Lee; Xiaoyuan Chen; Kang Choon Lee
Journal:  Bioconjug Chem       Date:  2011-07-22       Impact factor: 4.774

Review 3.  Multifunctional Poly(ethylene glycol)s.

Authors:  Boris Obermeier; Frederik Wurm; Christine Mangold; Holger Frey
Journal:  Angew Chem Int Ed Engl       Date:  2011-07-12       Impact factor: 15.336

Review 4.  TRAIL-mediated signaling in prostate, bladder and renal cancer.

Authors:  Christina Voelkel-Johnson
Journal:  Nat Rev Urol       Date:  2011-06-14       Impact factor: 14.432

5.  Multivalent and flexible PEG-nitrilotriacetic acid derivatives for non-covalent protein pegylation.

Authors:  Anna Mero; Tetsuya Ishino; Irwin Chaiken; Francesco M Veronese; Gianfranco Pasut
Journal:  Pharm Res       Date:  2011-05-25       Impact factor: 4.200

Review 6.  6xHis-Ni-NTA chromatography as a superior technique in recombinant protein expression/purification.

Authors:  J Crowe; H Döbeli; R Gentz; E Hochuli; D Stüber; K Henco
Journal:  Methods Mol Biol       Date:  1994

7.  PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy.

Authors:  Hai Hua Jiang; Tae Hyung Kim; Seulki Lee; Xiaoyuan Chen; Yu Seok Youn; Kang Choon Lee
Journal:  Biomaterials       Date:  2011-08-19       Impact factor: 12.479

8.  Improved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Su Young Chae; Tae Hyung Kim; Kyeongsoon Park; Cheng-Hao Jin; Sohee Son; Seulki Lee; Yu Seok Youn; Kwangmeyung Kim; Dong-Gyu Jo; Ick Chan Kwon; Xiaoyuan Chen; Kang Choon Lee
Journal:  Mol Cancer Ther       Date:  2010-06-01       Impact factor: 6.261

Review 9.  State of the art in PEGylation: the great versatility achieved after forty years of research.

Authors:  Gianfranco Pasut; Francesco M Veronese
Journal:  J Control Release       Date:  2011-11-07       Impact factor: 9.776

10.  Reversible site-selective labeling of membrane proteins in live cells.

Authors:  Emmanuel G Guignet; Ruud Hovius; Horst Vogel
Journal:  Nat Biotechnol       Date:  2004-03-21       Impact factor: 54.908

View more
  1 in total

Review 1.  Site-Specific PEGylation of Therapeutic Proteins.

Authors:  Jonathan K Dozier; Mark D Distefano
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.